Related Experiment Videos
Octreotide to treat postoperative chylothorax after cardiac operations in children
1Paediatric Surgical Unit, Harefield Hospital, Royal Brompton and Harefield NHS Trust, Harefield, Middlesex, United Kingdom.
Insights
Chylothorax in pediatric cardiac surgery patients can be effectively treated with octreotide (a synthetic somatostatin analogue) infusions. This treatment led to rapid resolution of chylothorax in all four patients studied.
Area of Science:
- Pediatric Cardiac Surgery
- Thoracic Surgery
- Gastroenterology
Background:
- Chylothorax is a serious complication following pediatric cardiac operations, leading to prolonged hospital stays and increased patient morbidity.
- Effective management strategies for post-operative chylothorax in pediatric cardiac surgery patients are crucial.
Observation:
- A cohort of 4 pediatric patients diagnosed with chylothorax post-cardiac surgery was treated.
- Treatment involved an infusion of octreotide, a synthetic somatostatin analogue, at a dose of 1 to 4 microg/kg per hour.
- Patients were also managed with either a medium-chain triglyceride diet or parenteral nutrition.
Findings:
- All 4 patients experienced resolution of chylothorax within 5 days of initiating octreotide treatment.
- No recurrence of chylothorax was observed in the patients during the study period.
- Resolution was achieved while patients were able to resume a normal diet.
Implications:
- Octreotide infusion represents a promising therapeutic option for managing chylothorax in pediatric cardiac surgical patients.
- This treatment may reduce hospitalization duration and improve patient outcomes.
- Further research is warranted to confirm efficacy and optimize treatment protocols in a larger population.
Abstract:
Chylothorax after pediatric cardiac operations is associated with significant morbidity and increased hospitalization. An octreotide (a synthetic somatostatin analogue) infusion (1 to 4 microg/kg per hour) with medium-chain triglyceride diet or parenteral nutrition was used in 4 pediatric cardiac surgical patients after chylothorax was diagnosed. Resolution followed within 5 days in all without recurrence, while on a normal diet.